{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:20:41Z","timestamp":1760908841189},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/rlu.0b013e3182a77cae","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T15:38:44Z","timestamp":1381160324000},"page":"882-884","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Whole-Body Versus Limited Whole-Body 18F-FDG PET\/CT Scan in Malignant Cutaneous Melanoma"],"prefix":"10.1097","volume":"38","author":[{"given":"Francisco Jose","family":"Lazaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan K.","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley","family":"Adams-Huet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210204","first-page":"1431","article-title":"Routine FDG PETCT in patients with a high risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases.","volume":"11","author":"Wagner","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-7-20210204","first-page":"925","article-title":"Impact of F-18 FDG PETCT in the restaging and management of patients with malignant melanoma.","volume":"31","author":"Elba","year":"2011","journal-title":"Nucl Med Commun"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.03.5634","article-title":"Diagnostic performance of whole body dual modality 18F-FDG PETCT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.","volume":"24","author":"Reinhardt","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-7-20210204","first-page":"1671","article-title":"Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.","volume":"10","author":"Kim","year":"2011","journal-title":"BMC Cancer"},{"key":"R5-7-20210204","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MNM.0b013e32833cb8b7","article-title":"Clinical and therapeutic impact of F-18 FDG PETCT whole-body acquisition including lower limbs in patients with malignant melanoma.","volume":"31","author":"Querellou","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R6-7-20210204","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1245\/s10434-010-1088-y","article-title":"Utility of preoperative F-18 FDG PETCT and brain MRI in melanoma patients with palpable lymph node metastases.","volume":"17","author":"Aukema","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R7-7-20210204","first-page":"202","article-title":"Is there an added clinical value of true whole body F-18 FDG PETCT imaging in patients with malignant melanoma Hell J Nucl Med.","volume":"15","author":"Tan","year":"2012","journal-title":""},{"key":"R8-7-20210204","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MNM.0b013e3283450878","article-title":"Response to the paper entitled clinical and therapeutic impact of F-18 FDG PETCT whole-body acquisition including lower limbs in patients with malignant melanoma.","volume":"32","author":"Davidson","year":"2011","journal-title":"Nucl Med Commun"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/MNM.0b013e3283450896","article-title":"Clinical and therapeutic impact of F-18 FDG PETCT whole-body acquisition including lower limbs on patients with malignant melanoma letter to the editor.","volume":"32","author":"Querellou","year":"2011","journal-title":"Nucl Med Commun"},{"key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0146-6453(99)00006-8","article-title":"Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).","volume":"28","author":"Valentin","year":"1998","journal-title":"Ann ICRP"},{"key":"R11-7-20210204","first-page":"2012","article-title":"ImPACT group. Available at: .","year":"27","journal-title":"Accessed October"},{"key":"R12-7-20210204","first-page":"2012","article-title":"Authority, Finland, PCXMCv1.5. Available at: .","year":"27","journal-title":"Accessed October"},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two sided confidence intervals for the single proportion: comparison of seven methods.","volume":"17","author":"Newcombe","year":"1988","journal-title":"Stat Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e3182a77cae","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:32:01Z","timestamp":1621884721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201311000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e3182a77cae","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}